Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 28, 2022Journal of ArrhythmologyOpen Access

Clinical characteristics of patients with various genetic types of long QT syndrome

View Full Paper
Ask AI
Bookmark
Share

Key result

LQT2 and multiple mutations linked to severe outcomes, with ~58% requiring CD implantation.

  • n=24

Why the study?

The study was conducted to evaluate clinical characteristics, adverse events, and outcomes in patients with various genetic types of long QT syndrome.

What are the clinical characteristics and outcomes associated with various genetic types of long QT syndrome?

Population

24 patients with a clinical diagnosis of LQTS

Comparison

Different genetic types of LQTS

Design

Observational cohort study

Follow-up

5 years

Authors

СКС. М. КомиссароваNCN. N. ChakovaЕРЕ. С. Ребеко

Discussion

Loading...

Member takes

Overview

LQT2 and multi-mutation LQTS may warrant closer surveillance; leaves open whether genotype-specific management improves outcomes.

Study Design

Type

Observational (n=24)

Structured PICO

What are the clinical characteristics and outcomes associated with various genetic types of long QT syndrome?

P
Population
24 patients with a clinical diagnosis of long QT syndrome (LQTS)
I
Intervention
Next generation sequencing (NGS) and clinical evaluation
O
Outcome
Clinical characteristics, adverse events, and outcomes (including sudden cardiac death, life-threatening arrhythmias, and cardioverter-defibrillator implantation)hard clinical

Patients with LQT2 and multiple genetic mutations exhibit more severe clinical manifestations, including higher rates of life-threatening arrhythmias and ICD implantation, compared to those with LQT1.

Cite This Study

Комиссарова et al. (2022) conducted an observational in Long QT syndrome (LQTS) (n=24). Genetic typing vs. Different genetic types was evaluated on Clinical characteristics, adverse events, and outcomes. LQT2 and multiple mutations were associated with the most severe clinical manifestations, including clinical death and QTc >500 ms, with 58.3% of the total cohort requiring CD implantation.

synapsesocial.com/papers/6a0ee42d8a6cf2089022a364https://doi.org/10.35336/va-2022-1-02
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association of Long QT Syndrome Loci and Cardiac Events Among Patients Treated With β-Blockers2004 · 602 citations
  2. 2ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data2010 · 15,962 citations
  3. 3Neural Control of Heart Rate Is an Arrhythmia Risk Modifier in Long QT Syndrome2008 · 115 citations
  4. 4High Efficacy of β-Blockers in Long-QT Syndrome Type 12009 · 312 citations
  5. 5Risk Stratification in the Long-QT Syndrome2003 · 1,461 citations